Were buying more of this health-care company amid an overdone sell-off - CNBC
| ABT Stock | MXN 2,368 47.09 1.95% |
Slightly above 62% of Abbott Laboratories' investor base is looking to short. The analysis of current outlook of investing in Abbott Laboratories suggests that many traders are alarmed regarding Abbott Laboratories' prospects. Abbott Laboratories' investing sentiment can be driven by a variety of factors including economic data, Abbott Laboratories' earnings reports, geopolitical events, and overall market trends.
Abbott |
Were buying more of this health-care company amid an overdone sell-off CNBC
Read at news.google.com
 |
Abbott Laboratories Fundamental Analysis
We analyze Abbott Laboratories' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abbott Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abbott Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Abbott Laboratories is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Abbott Laboratories Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Abbott Laboratories stock to make a market-neutral strategy. Peer analysis of Abbott Laboratories could also be used in its relative valuation, which is a method of valuing Abbott Laboratories by comparing valuation metrics with similar companies.
Peers
Abbott Laboratories Related Equities
| DAL | Delta Air | 1.70 | ||||
| GMXT | GMxico Transportes | 0.41 | ||||
| MNST | Monster Beverage | 0.09 | ||||
| DXC | DXC Technology | 0.00 | ||||
| FIHO12 | FibraHotel | 1.44 | ||||
| GCARSOA1 | Grupo Carso | 2.71 | ||||
| LUV | Southwest Airlines | 4.61 |
Additional Tools for Abbott Stock Analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.